Document Detail
Cardiac controlled release for arrhythmia therapy: Lidocaine-polyurethane matrix studies
Abstract/OtherAbstract :
Cardiac arrhythmias are the principal cause of sudden death due to heart disease, and current therapy is inadequate. A novel approach for formulating a lidocaine-polyurethane controlled release matrix and implanting this drug delivery system directly onto the arrhythmic epicardium is reported. Lidocaine-HCl-polyurethane matrices (28% w/w) were fabricated and studied for their in vitro drug release into physiologic buffer, and their in vivo pharmacologie effectiveness in rapidly converting ouabain-induced ventricular tachycardia in dogs to normal sinus rhythm. In vitro lidocaine release was successfully modulated as a result of variations in fabrication: compression molding, and stirring during polymer synthesis. Lidocaine release in vitro from the most rapidly releasing matrix formulation delivered more than 40% of the contained drug delivered after only 20 minutes, and the remainder slowly released over one week or more. Direct epimyocardial placement of this formulation resulted in the prompt conversion of ouabain-induced ventricular tachycardia to normal sinus rhythm in all experimental animals (n = 6) studied in 1.5 +/- 0.77 min(mean +/- standard error), while controls (n = 4) had persistent ventricular tachycardia for more than 60 min. Site-specific therapy was as rapid as intravenous administration, but with lower plasma lidocaine levels after comparable dosages. It is concluded that lidocaine-polyurethane controlled release matrices can be fabricated with a broad range of initial release profiles, and that these matrices can rapidly initiate the conversion of ouabain-induced ventricular tachycardia to normal sinus rhythm., Peer Reviewed, http://deepblue.lib.umich.edu/bitstream/2027.42/27025/1/0000013.pdf
Authors :
Sintov, Amnon, Scott, William A., Dick, Macdonald, II, Levy, Robert J.
Related Documents :
1597029 - Review article - brain natriuretic peptide in diagnosis and treatment of heart failure
32937749 - Heart and stroke encyclopedia
10034779 - The significance of total proximal anterior descending vessel occlusion
Contributors :
The Division of Pediatrie Cardiology, C.S. Mott Children's Hospital; The Department of Pediatrics, The University of Michigan Medical School; The Department of Pharmaceutics, The College of Pharmacy of the University of Michigan, Ann Arbor, MI 48 109, U.S.A., The Division of Pediatrie Cardiology, C.S. Mott Children's Hospital; The Department of Pediatrics, The University of Michigan Medical School; The Department of Pharmaceutics, The College of Pharmacy of the University of Michigan, Ann Arbor, MI 48 109, U.S.A., The Division of Pediatrie Cardiology, C.S. Mott Children's Hospital; The Department of Pediatrics, The University of Michigan Medical School; The Department of Pharmaceutics, The College of Pharmacy of the University of Michigan, Ann Arbor, MI 48 109, U.S.A., The Division of Pediatrie Cardiology, C.S. Mott Children's Hospital; The Department of Pediatrics, The University of Michigan Medical School; The Department of Pharmaceutics, The College of Pharmacy of the University of Michigan, Ann Arbor, MI 48 109, U.S.A.
Publication Detail :
Publisher :  Elsevier     Type :  -     Format :  1035622 bytes, 3118 bytes, application/pdf, text/plain    
Date Detail :
2006-04-07, 2006-04-07, 1988/12
Subject :
Chemistry, Biological Chemistry, Science, Health Sciences
Coverage :
-
Relation :
-
Source :
-
Copyright Information :
IndexNoFollow
Other Details :
Languages :  en_US    
Export Citation :
APA/MLA Format     Download EndNote     Download BibTex

Previous Document:  Reactions of vinyl selenoxides and ketenes via 3,3-sigmatropic rearrangement
Next Document:  Site-specific mutagenesis in Legionella pneumophila by allelic exchange using counterselectable ColE...